Innovative MedTech Inc. (IMTH)
USD 0.58
(34.88%)
USD 0.58
(34.88%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 794.01 Thousand USD | -52.4% |
| 2023 | 1.66 Million USD | 35.89% |
| 2022 | 1.22 Million USD | 261.58% |
| 2021 | 339.5 Thousand USD | 335.77% |
| 2020 | -144 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 100.0% |
| 2012 | -2544.00 USD | -101.57% |
| 2011 | 162.35 Thousand USD | 76.9% |
| 2010 | 91.77 Thousand USD | 252.07% |
| 2009 | -60.35 Thousand USD | -191.93% |
| 2008 | 65.64 Thousand USD | 87.85% |
| 2007 | 34.94 Thousand USD | -40.33% |
| 2006 | 58.56 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 441.9 Thousand USD | 0.44% |
| 2024 Q3 | 439.96 Thousand USD | 3.55% |
| 2024 Q2 | 424.89 Thousand USD | -6.03% |
| 2024 Q1 | 452.14 Thousand USD | 15.77% |
| 2023 Q2 | 408.89 Thousand USD | 6.1% |
| 2023 Q1 | 385.39 Thousand USD | 160.15% |
| 2023 FY | 1.66 Million USD | 35.89% |
| 2023 Q4 | 390.54 Thousand USD | -16.18% |
| 2023 Q3 | 465.91 Thousand USD | 13.95% |
| 2022 FY | 1.22 Million USD | 261.58% |
| 2022 Q4 | -640.66 Thousand USD | -551.13% |
| 2022 Q3 | 142.01 Thousand USD | -55.48% |
| 2022 Q2 | 318.99 Thousand USD | 255.91% |
| 2022 Q1 | 89.62 Thousand USD | -13.55% |
| 2021 Q1 | -6075.00 USD | 0.0% |
| 2021 Q4 | 103.67 Thousand USD | 117.89% |
| 2021 Q2 | -3575.00 USD | 41.15% |
| 2021 Q3 | 47.58 Thousand USD | 1430.97% |
| 2021 FY | 339.5 Thousand USD | 335.77% |
| 2020 FY | -144 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 100.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q1 | -105.24 Thousand USD | -215.23% |
| 2013 Q2 | - USD | 100.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q2 | 11.28 Thousand USD | -75.02% |
| 2012 FY | -2544.00 USD | -101.57% |
| 2012 Q4 | -33.38 Thousand USD | -126.22% |
| 2012 Q3 | 127.34 Thousand USD | 1028.18% |
| 2012 Q1 | 45.19 Thousand USD | 160.32% |
| 2011 Q1 | 6478.00 USD | -91.06% |
| 2011 FY | 162.35 Thousand USD | 76.9% |
| 2011 Q4 | 17.36 Thousand USD | -34.23% |
| 2011 Q3 | 26.39 Thousand USD | -64.03% |
| 2011 Q2 | 73.39 Thousand USD | 1032.97% |
| 2010 FY | 91.77 Thousand USD | 252.07% |
| 2010 Q1 | -78.76 Thousand USD | -1518.49% |
| 2010 Q2 | 9202.00 USD | 111.68% |
| 2010 Q3 | 28.41 Thousand USD | 208.84% |
| 2010 Q4 | 72.46 Thousand USD | 154.99% |
| 2009 Q1 | 19.74 Thousand USD | -18.14% |
| 2009 Q4 | 5553.00 USD | 47.84% |
| 2009 Q3 | 3756.00 USD | -58.68% |
| 2009 Q2 | 9090.00 USD | -53.97% |
| 2009 FY | -60.35 Thousand USD | -191.93% |
| 2008 Q2 | 8829.00 USD | 250.79% |
| 2008 Q1 | -5855.00 USD | -117.33% |
| 2008 Q3 | 12.94 Thousand USD | 46.66% |
| 2008 Q4 | 24.12 Thousand USD | 86.28% |
| 2008 FY | 65.64 Thousand USD | 87.85% |
| 2007 Q3 | 16.36 Thousand USD | 275.02% |
| 2007 Q4 | 33.78 Thousand USD | 106.48% |
| 2007 FY | 34.94 Thousand USD | -40.33% |
| 2007 Q1 | 42.43 Thousand USD | 163.01% |
| 2007 Q2 | -9350.00 USD | -122.03% |
| 2006 Q3 | 69.00 USD | -8.0% |
| 2006 Q2 | 75.00 USD | 0.0% |
| 2006 Q4 | 16.13 Thousand USD | 23282.61% |
| 2006 FY | 58.56 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | 53.269% |
| Ansell Limited | 624.8 Million USD | 99.873% |
| Ansell Limited | 624.8 Million USD | 99.873% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | 99.303% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -487.918% |
| Psykey, Inc. | 415.97 Thousand USD | -90.88% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.934% |
| ConvaTec Group Plc | 1.17 Billion USD | 99.932% |
| Encision Inc. | 3.13 Million USD | 74.68% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| LifePoint, Inc. | -71.35 Thousand USD | 1212.718% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 706.117% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -51.241% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -31.625% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -33.13% |
| SmileDirectClub, Inc. | 275.84 Million USD | 99.712% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 99.912% |
| SheerVision, Inc. | 2.17 Million USD | 63.509% |
| United Health Products, Inc. | -4857.00 USD | 16447.807% |
| Vasamed, Inc. | -69.38 Thousand USD | 1244.309% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -196.647% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -1408.04% |